作者: Seung Hyuk Baik , Nam Kyu Kim , Dae Ro Lim , Hyuk Hur , Byung So Min
DOI: 10.1245/S10434-013-2895-8
关键词:
摘要: Robot-assisted surgery is a new and emerging surgical procedure for rectal cancer patients. However, there lack of information regarding oncologic outcomes this procedure. We aimed to evaluate perioperative clinicopathologic resection using robotic instruments cancer. Data from patients (n = 370) diagnosed with stage I–IV disease sited below 15 cm the anal verge who underwent robot-assisted tumor-specific mesorectal excision consecutively June 2006 December 2010 were evaluated. Clinicopathologic follow-up data recorded prospectively analyzed retrospectively. Perioperative outcomes, postoperative complications, 3-year overall survival rate, disease-free rate analyzed. All excision. Of all pathologic stages, 15 (4.1 %) 0 (pathologic complete remission), 126 (34.1 %) I, 95 (25.7 %) II, 118 (31.9 %) III, 16 (4.3 %) IV. The was 93.1 % remission = 100 %, I = 99.2 %, II = 97.1 %, III = 90.1 %, IV = 48.4 %). 79.2 % I = 93.7 %, II = 79.8 %, III = 69.6 %, IV = 0.0 %). cumulative local recurrence 3.6 % (n = 10). circumferential margin positive 5.7 % (n = 21). Local developed in one patient systemic five total number complications 86 (23.2 %). These show feasibility safety terms outcomes.